世界のプロトロンビン複合体市場予測（～2028年）：500 IU /バイアル、600 IU /バイアル、1000 IU /バイアル、その他

• 英文タイトル：Global Prothrombin Complex Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8949 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

プロトロンビン複合体市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のプロトロンビン複合体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 プロトロンビン複合体市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・500 IU /バイアル、600 IU /バイアル、1000 IU /バイアル、その他 用途別セグメントは次のように区分されます。 ・血友病B、ビタミンK欠乏症、その他 世界のプロトロンビン複合体市場の主要な市場プレーヤーは以下のとおりです。 ・Takeda、CSL、Grifols、Octapharma、Hualan Biological、Meheco Xinxing Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、プロトロンビン複合体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なプロトロンビン複合体メーカーの企業概要、2019年～2022年までのプロトロンビン複合体の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なプロトロンビン複合体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別プロトロンビン複合体の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのプロトロンビン複合体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのプロトロンビン複合体市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびプロトロンビン複合体の産業チェーンを掲載しています。 ・第13、14、15章では、プロトロンビン複合体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Takeda、CSL、Grifols、Octapharma、Hualan Biological、Meheco Xinxing Pharma ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：500 IU /バイアル、600 IU /バイアル、1000 IU /バイアル、その他 ・用途別分析2017年-2028年：血友病B、ビタミンK欠乏症、その他 ・プロトロンビン複合体の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・プロトロンビン複合体のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・プロトロンビン複合体のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・プロトロンビン複合体の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・プロトロンビン複合体の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Prothrombin Complex market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prothrombin Complex market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hemophilia B accounting for % of the Prothrombin Complex global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 500 IU/Vial segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prothrombin Complex include Takeda, CSL, Grifols, Octapharma, and Hualan Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prothrombin Complex market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Market segment by Application can be divided into
Hemophilia B
Vitamin K Deficiency
Others
The key market players for global Prothrombin Complex market are listed below:
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prothrombin Complex product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prothrombin Complex, with price, sales, revenue and global market share of Prothrombin Complex from 2019 to 2022.
Chapter 3, the Prothrombin Complex competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prothrombin Complex breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prothrombin Complex market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prothrombin Complex.
Chapter 13, 14, and 15, to describe Prothrombin Complex sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Prothrombin Complex Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prothrombin Complex Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Prothrombin Complex Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Prothrombin Complex Market Size & Forecast
1.4.1 Global Prothrombin Complex Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prothrombin Complex Sales in Volume (2017-2028)
1.4.3 Global Prothrombin Complex Price (2017-2028)
1.5 Global Prothrombin Complex Production Capacity Analysis
1.5.1 Global Prothrombin Complex Total Production Capacity (2017-2028)
1.5.2 Global Prothrombin Complex Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prothrombin Complex Market Drivers
1.6.2 Prothrombin Complex Market Restraints
1.6.3 Prothrombin Complex Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Prothrombin Complex Product and Services
2.1.4 Takeda Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Prothrombin Complex Product and Services
2.2.4 CSL Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Prothrombin Complex Product and Services
2.3.4 Grifols Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Prothrombin Complex Product and Services
2.4.4 Octapharma Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hualan Biological
2.5.1 Hualan Biological Details
2.5.2 Hualan Biological Major Business
2.5.3 Hualan Biological Prothrombin Complex Product and Services
2.5.4 Hualan Biological Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Meheco Xinxing Pharma
2.6.1 Meheco Xinxing Pharma Details
2.6.2 Meheco Xinxing Pharma Major Business
2.6.3 Meheco Xinxing Pharma Prothrombin Complex Product and Services
2.6.4 Meheco Xinxing Pharma Prothrombin Complex Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prothrombin Complex Breakdown Data by Manufacturer
3.1 Global Prothrombin Complex Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prothrombin Complex Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prothrombin Complex
3.4 Market Concentration Rate
3.4.1 Top 3 Prothrombin Complex Manufacturer Market Share in 2021
3.4.2 Top 6 Prothrombin Complex Manufacturer Market Share in 2021
3.5 Global Prothrombin Complex Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prothrombin Complex Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prothrombin Complex Market Size by Region
4.1.1 Global Prothrombin Complex Sales in Volume by Region (2017-2028)
4.1.2 Global Prothrombin Complex Revenue by Region (2017-2028)
4.2 North America Prothrombin Complex Revenue (2017-2028)
4.3 Europe Prothrombin Complex Revenue (2017-2028)
4.4 Asia-Pacific Prothrombin Complex Revenue (2017-2028)
4.5 South America Prothrombin Complex Revenue (2017-2028)
4.6 Middle East and Africa Prothrombin Complex Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prothrombin Complex Sales in Volume by Type (2017-2028)
5.2 Global Prothrombin Complex Revenue by Type (2017-2028)
5.3 Global Prothrombin Complex Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prothrombin Complex Sales in Volume by Application (2017-2028)
6.2 Global Prothrombin Complex Revenue by Application (2017-2028)
6.3 Global Prothrombin Complex Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prothrombin Complex Sales by Type (2017-2028)
7.2 North America Prothrombin Complex Sales by Application (2017-2028)
7.3 North America Prothrombin Complex Market Size by Country
7.3.1 North America Prothrombin Complex Sales in Volume by Country (2017-2028)
7.3.2 North America Prothrombin Complex Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prothrombin Complex Sales by Type (2017-2028)
8.2 Europe Prothrombin Complex Sales by Application (2017-2028)
8.3 Europe Prothrombin Complex Market Size by Country
8.3.1 Europe Prothrombin Complex Sales in Volume by Country (2017-2028)
8.3.2 Europe Prothrombin Complex Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prothrombin Complex Sales by Type (2017-2028)
9.2 Asia-Pacific Prothrombin Complex Sales by Application (2017-2028)
9.3 Asia-Pacific Prothrombin Complex Market Size by Region
9.3.1 Asia-Pacific Prothrombin Complex Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prothrombin Complex Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prothrombin Complex Sales by Type (2017-2028)
10.2 South America Prothrombin Complex Sales by Application (2017-2028)
10.3 South America Prothrombin Complex Market Size by Country
10.3.1 South America Prothrombin Complex Sales in Volume by Country (2017-2028)
10.3.2 South America Prothrombin Complex Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prothrombin Complex Sales by Type (2017-2028)
11.2 Middle East & Africa Prothrombin Complex Sales by Application (2017-2028)
11.3 Middle East & Africa Prothrombin Complex Market Size by Country
11.3.1 Middle East & Africa Prothrombin Complex Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prothrombin Complex Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prothrombin Complex and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prothrombin Complex
12.3 Prothrombin Complex Production Process
12.4 Prothrombin Complex Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prothrombin Complex Typical Distributors
13.3 Prothrombin Complex Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---